On the function of placental corticotropin-releasing hormone: A role in maternal-fetal conflicts over blood glucose concentrations

Biological Reviews

Volumn 87, Issue 4, 2012, Pages 856-873

  Gangestad, Steven W ^a   Caldwell Hooper, Ann E ^a   Eaton, Melissa A ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Corticotropin releasing hormone; Cortisol; Fetal programming; Maternal fetal conflict; Placental hormones

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ADAPTATION; ARTICLE; FEMALE; FETOMATERNAL TRANSFUSION; GLUCOSE BLOOD LEVEL; HUMAN; PHYSIOLOGY; PLACENTA; PREGNANCY;

ADAPTATION, PHYSIOLOGICAL; BLOOD GLUCOSE; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY;

PRIMATES; SIMIIFORMES;

EID: 84867139769     PISSN: 14647931     EISSN: 1469185X     Source Type: Journal    
DOI: 10.1111/j.1469-185X.2012.00226.x     Document Type: Article

References (182)

1. Ahmed, S. A. & Shalayel, M. H. (1999). Role of cortisol in the deterioration of glucose tolerance in Sudanese pregnant women. East African Medical Journal 76, 465-467.
2. Albiston, A. L., Obeyesekere, V. R., Smith, R. E. & Krozowski, Z. S. (1995). Cloning and tissue distribution of the human 11-beta-dydrosteroid dehydrogenase type-2 enzyme. Molecular and Cellular Endocrinology 105, R11-R17.
3. Anderson, A. B., Gennser, G., Jeremy, J. Y., Ohrlander, S., Sayers, L. & Turnbull, A. C. (1977). Placental transfer and metabolism of betamethasone in human pregnancy. Obstetrics and Gynecology 49, 471-474.
4. Andrews, R. C. & Walker, B. R. (1999). Glucocorticoids and insulin resistance: old hormones, new targets. Clincial Science 96, 513-523.
5. Austin, M. P. & Leader, L. (2000). Maternal stress and obstetric and infant outcomes: epidemiologial findings and neuroendocrine mechanisms. Australian and New Zealand Journal of Obstetrics and Gynaecology 40, 331-337.
6. Banks, B. A., Cnaan, A., Morgan, M. A., Parer, J. T., Merrill, J. D., Ballard, P. L. & Ballard, R. A. (1999). Multiple courses of antenatal corticosteroids and outcome of premature neonates. American Journal of Obstetrics and Gynecology 181, 709-717.
7. Barker, D. J. P. (2004). The developmental origins of adult disease. Journal of the American College of Nutrition 23, 588S-595S.
8. Barker, D. J. P., Eriksson, J. G., Forsen, T. & Osmund, C. (2002). Fetal origins of adult disease: strength of effects and biological basis. International Journal of Epidemiology 31, 1235-1239.
9. Barnard, R., Fung-Yee, C. & McIntyre, H. D. (1997). Growth-hormone-binding protein in normal and pathologic gestation: correlations with maternal diabetes and fetal growth. Journal of Clinical Endocrinology and Metabolism 82, 1879-1884.
10. Baumann, G. (2001). Growth hormone binding protein 2001. Journal of Pediatric Endocrinology and Metabolism 14, 355-375.
11. Bjorklund, A. O., Adamson, U. K. C., Carlstrom, K. A. M., Hennen, G., Igout, A., Lines, P. E. S. & Westgren, L. M. R. (1998). Placental hormones during hyperglycemia in pregnant women with insulin-dependent diabetes mellitus: evidence of an active role for placenta in hormonal counterregulation. British Journal of Obstetrics and Gynaecology 105, 649-655.
12. Bloom, S. L., Sheffield, J. S., McIntyre, D. D. & Leveno, K. J. (2001). Antenatal dexamethasone and decreased birth weight. Obstetrics and Gynecology 97, 485-490.
13. Blumenfeld, Z., Barkey, R. J., Youdim, M. B., Brandes, J. M. & Amit, T. (1992). Growth hormone (GH)-binding protein regulation by estrogen, progesterone, and gonadotropins in humans: the effect of ovulation induction with menopausal gonotropins, GH, and gestation. Journal of Clinical Endocrinology and Metabolism 75, 1242-1249.
14. Bolten, M. I., Wurmser, H., Buske-Kirschbaum, A., Popousek, M., Pirke, K. & Hellhammer, D. (2011). Cortisol levels in pregnancy as a psychobiological predictor for birth weight. Archives of Women's Mental Health 14, 33-41.
15. Bowman, M. E., Lopata, A., Jaffe, R. B., Golos, T. G., Wickings, J. & Smith, R. (2001). Corticotropin-releasing hormone-binding protein in primates. American Journal of Primatology 53, 123-130.
16. Brunton, P. J. & Russell, J. A. (2008). The expectant brain: adapting for motherhood. Nature Reviews Neuroscience 9, 11-25.
17. Brunton, P. J., Russell, J. A. & Douglas, A. J. (2008). Adaptive responses of the maternal hypothalamic-pituatary-adrenal axis during pregnancy and lactation. Journal of Neuroendocrinology 20, 764-778.
18. Campbell, E. A., Linton, E. A., Wolfe, C. D., Scrages, P. R., Jones, M. T. & Lowry, P. J. (1987). Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. Journal of Clinical Endocrinology and Metabolism 64, 1054-1059.
19. Chambers, P. L. & Hearn, J. P. (1985). Embryonic, fetal and placental development in the common marmoset monkey (Callithrix-jacchus). Journal of Zoology 207, 545-561.
20. Chan, E. Q., Smith, R., Lewin, T., Brimsmead, M. W., Zhang, H. P., Cubis, J., Thornton, K. & Hurt, D. (1993). Plasma corticotropin-releasing hormone, beta-endorphin and cortisol interrelationships during human pregnancy. Acta Endocrinology 128, 339-344.
21. Chellakooty, M., Skibsted, L., Skouby, S. O., Anderson, A., Peterson, J. H., Main, K. M., Skakkebaek, N. E. & Juul, A. (2004). Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight. Journal of Clinical Endocrinology and Metabolism 87, 2734-2739.
22. Chibbar, R., Wong, S., Miller, F. D. & Mitchell, B. F. (1995). Estrogen stimulates oxytocin gene-expression in human chorio-decidua. Journal of Clinical Endocrinology and Metabolism 80, 567-572.
23. Choy, M. Y., Leung, T. N. & Lau, T. K. (2004). Corticotropin-releasing hormone peptide and human first-trimester placental growth. Early Human Development 79, 77-80.
24. Clark, P. M., Hindmarsh, P. C., Shiell, A. W., Law, C. M., Honour, J. W. & Barker, D. J. P. (1996). Size at birth and adrenocortisol function in childhood. Clinical Endocrinology 45, 721-726.
25. Class, Q. A., Lichtenstein, P., Langstrom, N. & D'Onofrio, B. M. (2011). Timing of prenatal maternal exposure to severe life events and adverse pregnancy outcomes: a population study of 2.6 million pregnancies. Psychosomatic Medicine 73, 234-241.
26. Dahlgren, J., Boguszewski, M., Rosberg, S. & Albertsson-Wikland, K. (1998). Adrenal steroid hormones in short children born small for gestational age. Clinical Endocrinology 49, 353-361.
27. Damjanovoc, S. S., Stojic, R. V., Lalic, N. M., Jotic, A. Z., Macut, D. P., Ognjanovic, S. I., Petakov, M. S. & Popovic, B. M. (2009). Relationship between basal metabolic rate and cortisol secretion throughout pregnancy. Endocrine 35, 262-268.
28. Davis, E. P., Glynn, L. M., Waffarn, F. & Sandman, C. A. (2011a). Prenatal maternal stress programs infant stress regulation. Journal of Child Psychology and Psychiatry 52, 119-129.
29. Davis, E. P., Waffarn, F. & Sandman, C. A. (2011b). Prenatal treatment wth glucocorticoids sensitizes the HPA axis response to stress among full-term infants. Developmental Psychobiology 53, 175-183.
30. Davis, E. P., Waffarn, F., Uy, C., Hobel, C. J., Glynn, L. M. & Sandman, C. A. (2009). Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation. Journal of Perinatology 29, 731-737.
31. Diego, M. A., Field, T., Hernandez-Reif, M., Schanberg, S., Kuhn, C. & Gonzalez-Quintero, V. H. (2009). Prenatal depression restricts fetal growth. Early Human Development 85, 65-70.
32. Diego, M. A., Jones, N. A., Field, T., Hernandez-Reif, M., Schanberg, S., Kuhn, C. & Gonzalez-Garcia, A. (2006). Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosomatic Medicine 68, 747-753.
33. Donoghue, J. F., Leitch, I. M., Boura, A. L. A., Walters, W. A. W., Giles, W. B., Smith, R. & Read, M. A. (2000). Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension. Placenta 21, 711-717.
34. Douglas, A. J. (2010). Baby on board: do responses to stress in the maternal brain mediate adverse pregnancy outcomes? Frontiers in Neuroendocrinology 31, 359-376.
35. Dunkel Schetter, C. & Glynn, L. A. (2011). Stress in pregnancy: empirical evidence and theoretical issues to guide interdisciplinary research. In Handbook of Stress Science, Chapter 24 (eds R. Contrada and A. Baum), pp. 321-343, Springer, New York.
36. Edwards, C. R. W., Benediktsson, R., Lindsay, R. S. & Seckl, J. R. (1996). 11 beta-hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects. Steroids 61, 263-269.
37. Ellison, P. T. (2001). On Fertile Ground Harvard University Press, Cambridge.
38. Ellison, P. T. (2003). Energetics and reproductive effort. American Journal of Human Biology 15, 342-351.
39. Ellison, P. T. (2008). Energetics, reproductive ecology, and human evolution. Paleoanthropology 2008, 172-200.
40. Ellison, P. T. (2010). Fetal programming and fetal psychology. Infant and Child Development 19, 6-20.
41. Entringer, S., Buss, C., Shirtcliff, E. A., Cammack, A. L., Yim, I. S., Chicz-Demet, A., Sandman, C. A. & Wadhwa, P. D. (2010). Attenuation of maternal psychophysiological stress responses and the maternal cortisol awakening response over the course of human pregnancy. Stress 13, 258-268.
42. Florio, P., Imperatore, A., Sanseverino, F., Torricelli, M., Rise, F. M., Lowry, P. J. & Petraglia, F. (2004). The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia. Journal of Clinical Endocrinology and Metabolism 89, 4673-4677.
43. Florio, P., Severi, F. M., Ciarmela, P., Fiore, G., Calonaci, G., Merola, A., De Felice, C., Palumba, M. & Petraglia, F. (2002). Placental stress factors and the maternal-fetal adaptive response: the corticotropin-releasing factor family. Endocrine 19, 91-102.
44. French, N. P., Hagan, R., Evans, S. F., Godfrey, M. & Newnham, J. P. (1999). Repeated antenatal steroids: size and birth and subsequent development. American Journal of Obstetrics and Gynecology 180, 114-121.
45. Frim, D. M., Emanuel, R. L., Robinson, B. G., Smas, C. M., Adler, G. K. & Majzoub, J. A. (1988). Characterization and gestational regulation of corticotropin-releasing hormone messenger-RNA in human placenta. Journal of Clinical Investigation 82, 287-292.
46. Fuglsang, J., Moller, N., Ledet, T. & Ovesen, P. (2008). Effects of glucose, glycerol, 3-hydroxybutyrate, insulin, and leptin on placental growth hormone secretion in placental explants. Hormone and Metabolic Research 40, 189-193.
47. Germain, S. J., Sacks, G. P., Soorana, S. R., Sargent, I. L. & Redman, C. W. (2007). Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syntiotrophoblast microparticles. Journal of Immunology 178, 5949-5956.
48. Gitau, R., Cameron, A., Fisk, N. M. & Glover, V. (1998). Fetal exposure to maternal cortisol. Lancet 352, 707-708.
49. Gitau, R., Fisk, N. M., Teizerira, J. M., Cameron, A. & Glover, V. (2001). Fetal hypothalamic-pituatary-adrenal stress responses to invasive procedures are independent of maternal responses. Journal of Clinical Endocrinology and Metabolism 86, 104-109.
50. Glover, V., Bergman, K., Sarker, P. & O'Connor, T. G. (2009). Association between maternal and amniotic fluid is moderated by maternal anxiety. Psychoendocrinology 34, 430-435.
51. Gluckman, P. & Hanson, M. (2006). Mismatch: Why Our World No Longer Fits Our Bodies Oxford University Press, Oxford.
52. Gluckman, P. D. & Hanson, M. (2010). The plastic human. Infant and Child Development 19, 21-26.
53. Glynn, L. M., Dunkel Schetter, C., Chicz-DeMet, A., Hobel, C. J. & Sandman, C. A. (2007). Ethnic differences in adrenocorticotropin hormone, cortisol and corticotropin-releasing hormone during pregnancy. Peptides 28, 1155-1161.
54. Glynn, L. M., Dunkel Schetter, C., Wadhwa, P. D. & Sandman, C. A. (2004). Pregnancy affects appraisal of negative life events. Journal of Psychosomatic Research 56, 47-562.
55. Goland, R. S., Jozak, S. & Conwell, I. (1994). Placental corticotropin-releasing hormone and the hypercortisolism of pregnancy. American Journal of Obstetrics and Gynecology 171, 1287-1291.
56. Goland, R. S., Jozak, S., Warren, W. B., Conewll, I. M., Stark, R. I. & Tropper, P. J. (1993). Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. Journal of Clinical Endocrinology and Metabolism 77, 1174-1179.
57. Goland, R. S., Tropper, P. J., Warren, W. B., Stark, R. I., Jozak, S. M. & Conwell, I. M. (1995). Concentrations of corticotrophin-releasing hormone in the umbilical-cord blood of pregnancies complicated by pre-eclampsia. Reproduction Fertility and Development 7, 1227-1230.
58. Goland, R. S., Wardlaw, S. L., Fortman, J. D. & Stark, R. I. (1992). Plasma corticotropin-releasing factor concentrations in the baboon during pregnancy. Endocrinology 131, 1782-1786.
59. Gould, S. J. & Vrba, E. S. (1982). Exaptation: a missing term in the science of form. Paleobiology 8, 4-15.
60. Grammatopoulos, D. (2008). Placental corticotropin-releasing hormone and its receptors in human pregnancy and labour: still a scientific enigma. Journal of Neuroendocrinology 20, 432-438.
61. Grigorakis, S. I., Alevisaki, M., Beis, C., Anastasiou, E., Alevisaki, C. C. & Souvatzoglou, A. (2000). Hormonal parameters in gestational diabetes mellitus during the third trimester: high glucagons levels. Gynecologic and Obstetric Investigation 49, 106-109.
62. Haig, D. (1993). Genetic conflicts in human pregnancy. Quarterly Review of Biology 68, 495-527.
63. Haig, D. (2007). Putting up resistance: maternal-fetal conflict over the control of uteroplacental blood flow. In Endothelial Biomedicine (ed. W. C. Aird), pp. 135-141, Cambridge University Press, Cambridge.
64. Haig, D. (2008). Placental growth hormone-related proteins and prolactin-related proteins. Placenta 22, S36-S41.
65. Handwerger, S. & Freemark, M. (2000). The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. Journal of Pediatric Endocrinology and Metabolism 14, 343-356.
66. Harville, E. W., Savitz, D. A., Dole, N., Herring, A. H. & Thorp, J. M. (2009). Stress questionnaires and stress biomarkers during pregnancy. Journal of Women's Health 18, 1425-1433.
67. Harville, E. W., Savitz, D. A., Dole, N., Herring, A. H., Thorp, J. M. & Light, K. C. (2008). Stress and placental resistance measured by Doppler ultrasound in early and mid-pregnancy. Ultrasound in Obstetrics and Gynecology 32, 23-30.
68. Harville, E., Xiong, X. & Buekens, P. (2010). Disasters and perinatal health: a systematic review. Obstetrical and Gynecological Survey 65, 713-728.
69. Hauguel-del Mouzon, S., Lepercq, J. & Catalano, P. (2006). The known and unknown of leptin in pregnancy. American Journal of Obstetrics and Gynecology 194, 1537-1545.
70. Herrmann, T. S., Siega-Riz, A. M., Hobel, C. J., Aurora, C. & Dunkel Schetter, C. (2001). Prolonged periods without food intake during pregnancy increase risk for elevated maternal corticotropin-releasing hormone concentrations. American Journal of Obstetrics and Gynecology 185, 403-412.
71. Hillhouse, E. W. & Grammatopoulos, D. K. (2006). The molecular mechanisms underlying the regulation of the biological activity of corticotrophin-releasing hormone receptors: implications for physiology and pathophysiology. Endocrine Reviews 27, 260-286.
72. Hobel, M. D., Dunkel Schetter, C., Roesch, S. C., Castro, L. C. & Arora, C. P. (1999). Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. American Journal of Obstetrics and Gynecology 180, S257-S263.
73. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature 444, 860-867.
74. Imperatore, A., Rolfo, A., Petraglia, F., Challis, J. R. G. & Caniggia, I. (2010). Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3. Reproductive Sciences 17, 833-843.
75. Inder, W. J., Prickett, T. C. R., Ellis, M. J., Hull, L., Reid, R., Benny, P. S., Livesey, J. H. & Donald, R. A. (2001). The utility of plasmas CRH as a predictor of preterm delivery. Journal of Clinical Endocrinology and Metabolism 86, 5706-5710.
76. Ishimoto, H. & Jaffe, R. B. (2011). Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocrine Reviews 32, 37-355.
77. Jaquish, C. E., Toal, R. L., Tardif, S. D. & Carson, R. L. (1995). Use of ultrasound to monitor prenatal growth and development in the common marmoset (Callithrix-jacchus). American Journal of Primatology 36, 259-275.
78. Jobe, A. H., Newnham, J. P., Moss, T. J. & Ikegami, M. (2003). Differential effects of maternal betamethasone and cortisol on lung maturation and growth in fetal sheep. American Journal of Obstetrics and Gynecology 188, 22-28.
79. Jobe, A. H., Wada, N., Berry, L. M., Ikegami, M. & Ervin, M. G. (1998). Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. American Journal of Obstetrics and Gynecology 178, 880-885.
80. Jones, J. H. (2005). Fetal programming: adaptive life-history tactics or making the best of a bad start? American Journal of Human Biology 18, 133-140.
81. Jones, C. T., Gu, W. & Parer, J. T. (1989). Production of corticotropin releasing hormone by the sheep placenta invivo. Journal of Developmental Physiology 11, 97-101.
82. Kajantie, E., Phillips, D. I. W., Andersson, S., Barker, D. J. P., Dunkel, L., Forsen, T., Osmund, C., Tuominen, J., Woods, P. J. & Ericsson, J. (2002). Size at birth, gestational age and cortisol secretion in adult life: foetal programming of both hyper- and hypocortisolism? Clinical Endocrinology 57, 635-641.
83. Kammerer, M., Adams, D., von Castelberg, B. & Glover, V. (2002). Pregnant women become insensitive to cold stress. BMC Pregnancy and Childbirth 2, 8.
84. Keller-Wood, M. (1998). ACTH responses to CRF and AVP in pregnant and nonpregnant ewes. American Journal of Physiology 274, R1762-R1768.
85. Keller-Wood, M., Wood, C. E., Kane, C. & Manlove, E. (1991). Corticotropin-releasing factor in the ovine fetus and pregnancy ewe: role of placenta. American Journal of Physiology 261, R995-R1002.
86. Khashan, A. S., McNamee, R., Abel, K. M., Pedersen, M. G., Webb, R. T., Kenny, L. C., Mortensen, P. B. & Baker, P. N. (2008). Reduced infant birthweight consequent upon maternal exposure to severe life events. Psychosomatic Medicine 70, 688-694.
87. Krogh-Madsen, R., Plomgaard, P., Moller, K., Mittendorfer, B. & Pedersen, B. K. (2006). Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. American Journal of Physiology 291, E108-E114.
88. Laatikainen, T., Virtanen, T., Kaaja, R. & Salminenlappalainen, K. (1991). Corticotropin-releasing hormone in maternal and cord plasma in preeclampsia. European Journal of Obstetrics Gynecology and Reproductive Biology 39, 19-24.
89. Lappas, M., Permezel, M. & Rice, G. E. (2005). Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferators-activated receptor-γ and extracellularly regulated kinase 1/2. Endocrinology 146, 3334-3342.
90. Latendresse, G. & Ruiz, R. J. (2010). Maternal coping style and perceived adequacy of income predict CRH levels at 14-20 weeks of gestation. Biological Research for Nursing 12, 125-136.
91. Levitt, N. S., Lambert, E. V., Woods, D., Hales, C. N., Andrew, R. & Seckl, J. R. (2000). Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young South African adults: early programming of cortisol axis. Journal of Clinical Endocrinology and Metabolism 85, 4611-4618.
92. Linnemann, K., Malek, A., Sager, R., Blum, W. F., Schneider, H. & Fusch, C. (2000). Leptin production and release in the dually in vitro perfused human placenta. Journal of Clinical Endocrinology and Metabolism 85, 4298-4301.
93. Linton, E. A., Behan, D. P., Saphier, P. W. & Lowry, P. J. (1990). Corticotropin-releasing hormone (CRH)-binding protein: reduction in the adrenocorticotropin-releasing activity of placental but not hypothalamic CRH. Journal of Clinical Endocrinology and Metabolism 70, 1574-1580.
94. Linton, E. A., Perkins, A. V., Woods, R. J., Eben, F., Wolfe, C. D. A., Behna, D. P., Potter, E., Vale, W. W. & Lowry, P. J. (1993). Corticotropin-releasing hormone-binding protein (CRH-BP): plasma levels creases during the 3rd trimester of normal human pregnancy. Journal of Clinical Endocrinology and Metabolism 76, 260-262.
95. Lovell, T. M., Woods, R. J., Butlin, D. J., Brayley, K. J., Manyonda, I. T., Jarvis, J., Howell, S. & Lowry, P. J. (2007). Identification of a novel mammalian post-translational modification, phoshocholine, on placental secretory polypeptides. Journal of Molecular Endocrinology 39, 189-198.
96. Lowry, P. J. (2008). The placenta is simply a neuroendocrine parasite. Journal of Neuroendocrinology 20, 700-704.
97. Magiakou, M. A., Mastorakos, G., Rabin, D., Margioris, A. N., Dubbert, B., Calogero, A. E., Tsigos, C., Munson, P. J. & Chrousos, G. P. (1996). The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clinical Endocrinology 44, 419-428.
98. Makrigiannakis, A., Zoumakis, E., Kalantaridou, S. & Chrousos, G. (2004). Endometrial and placental CRH as regulators of human embryo implantation. Journal of Reproductive Immunology 62, 53-59.
99. Mancuso, R. A., Dunkel Schetter, C., Rini, C. M., Roesch, S. C. & Hobel, C. J. (2004). Maternal prenatal anxiety and corticotropin-releasing hormone associated with preterm delivery. Psychosomatic Medicine 66, 762-769.
100. Mastorakos, G., Karoutsou, E. I. & Mizamtsidi, M. (2006). Corticotropin releasing hormone and the immune/inflammatory response. European Journal of Endocrinology 155, S77-S84.
101. McIntyre, H. D., Chang, A. M., Callaway, L. K., Cowley, D. M., Dyer, A. R., Radaelli, T., Farrell, K. A., Huston-Presley, L., Amini, S. B., Kerwan, J. P. & Catalano, P. M. (2010). Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care 33, 356-360.
102. McIntyre, H. D., Russell, A., Serek, T., Veveris-Lowe, T., Cotterill, A., Cowley, D. & Barnard, R. (2002). Placental growth hormone is not suppressed by oral glucose loading in normal human pregnancy. Hormone and Metabolic Research 34, 250-253.
103. McIntyre, H. D., Serek, R., Crane, D. I., Veveris-Lowe, T., Parry, A., Johnson, S., Leung, K. C., Ho, K. K. Y., Bougoussa, M., Hennen, G., Igout, A., Chan, F-Y., Cowley, D., Cotterill, A. & Barnard, R. (2000). Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. Journal of Clinical Endocrinology and Metabolism 85, 1143-1150.
104. McLean, M., Bisits, A., Davies, J., Lowry, R. & Smith, R. (1995). A placental clock controlling the length of human pregnancy. Nature Medicine 1, 460-463.
105. McLean, M. & Smith, R. (2001). Corticotropin-releasing hormone and human parturition. Reproduction 121, 493-501.
106. Mirlesse, V., Frankenne, F., Alsat, E., Poncelet, M., Hennen, G. & Evain-Brion, D. (1993). Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatric Research 34, 439-442.
107. Mittal, P., Espinoza, J., Hassan, S., Kusanovic, J. P., Edwin, S. S., Nien, J. K., Gotsch, F., Than, N. G., Erez, O., Mazaki-Tovi, S. & Romero, R. (2008). Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. Journal of Maternal-Fetal and Neonatal Medicine 20, 651-659.
108. Muglia, L. J., Jacobson, L., Dikkes, P. & Majzoub, J. A. (1995). Corticotropin-releasing hormone deficiency reveals major fetal but not adult gluticocorticoid need. Nature 373, 427-432.
109. Murphy, B. E. P., Clark, S. J., Donald, I. R., Pinsky, M. & Vedady, D. (1974). Conversion of maternal cortisol to cortisone during placental transfer to human fetus. American Journal of Obstetrics and Gynecology 118, 538-541.
110. Murphy, V. E., Fittock, R. J., Zarzycki, P. K., Delahunty, M. M., Smith, R. & Clifton, V. L. (2006). Metabolism of synthetic steroids by the human placenta. Placenta 28, 46-49.
111. Nelson, R. J. (2005). An Introduction to Behavioral Endocrinology Third Edition. Sinauer Associates, Sunderland.
112. Ni, X. T., Duan, T., Yang, Z., Guo, C. M., Li, J. N. & Sun, K. (2009). Role of human chorionic gonadotropin in maintaining 11β-hydroxysteroid dehydrogenase type 2 expression in human placental syntiotrophoblasts. Placenta 30, 1023-1028.
113. Norris, A. W., Wang, C., Yao, J., Walsh, S. A., Sawatzke, A. B., Hu, S., Sunderland, J. J., Segar, J. L. & Ponto, L. L. B. (2011). Effect of insulin and dexamethasone on fetal assimilation of maternal glucose. Endocrinology 152, 255-262.
114. O'Keane, V., Lightman, S., Marsh, M., Pawlby, S., Papdopoulos, A. S., Taylor, A., Moore, R. & Patrick, K. (2011). Increased pituitary-adrenal activation and shortened gestation in a sample of depressed pregnant women: a pilot study. Journal of Affective Disorders 130, 300-305.
115. Papadopoulou, E., Sifakis, S., Fragouli, Y., Karkavitsas, N., Koumantakis, E. & Kalmanti, M. (2006). Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia. Growth Hormone and IGF Research 16, 290-296.
116. Papadopoulou, E., Sifakis, S., Giahnakis, E., Karkavitsas, N., Koumantakis, W. & Kalmanti, M. (2008). Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome. Fetal Diagnosis and Therapy 23, 211-216.
117. Patel, N., Alsat, E., Igout, A., Baron, F., Hennen, G., Porquet, D. & Evainbrion, D. (1995). Glucose inhibits human placental GH secretion, in-vitro. Journal of Clinical Endocrinology and Metabolism 80, 1743-1746.
118. Pearson, R. M., Lightman, S. L. & Evans, J. (2009). Emotional sensitivity for mother hood: late pregnancy is associated with enhanced accuracy to encode emotional faces. Hormones and Behavior 56, 557-563.
119. Pepels, P. P. L. M., Spaanderman, M. E. A., Bulten, J., Smits, P. B. A. M., Hermus, A. R. M. M., Lotgering, F. K. & Sweep, C. G. J. (2009). Placental urocortins and CRF in late gestation. Placenta 30, 483-490.
120. Pepels, P. P. L. M., Spaanderman, M. E. A., Hermus, A. R. M. M., Lotgering, F. K. & Sweep, C. G. J. (2010). Placental urocortin-2 and -3: endocrine or paracrine functioning during healthy pregnancy? Placenta 31, 475-481.
121. Perkins, A. V. & Linton, E. A. (1995). Placental corticotropin-releasing hormone: there by accident or design. Journal of Endocrinology 147, 377-381.
122. Perkins, A. V., Wolfe, C. D. A., Eben, F., Soothill, P. & Linton, E. A. (1995). Corticotropin-releasing hormone-binding protein in human fetal plasma. Journal of Endocrinology 77, 919-924.
123. Petraglia, F., Imperatore, A. & Challis, J. R. G. (2010). Neuroendocrine mechanisms in pregnancy and parturition. Endocrine Reviews 31, 783-816.
124. Petraglia, F., Potter, E., Cameron, V. A., Suttin, S., Behan, D. P., Woods, R. J., Sawchenko, P. E., Lowry, P. J. & Vale, W. (1993). Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. Journal of Clinical Endocrinology and Metabolism 77, 919-924.
125. Phillips, D. I. W., Barker, D. J. P., Fall, C. H. D., Seckl, J. R., Whorwood, C. B., Wood, P. J. & Walker, B. R. (1998). Elevated cortisol concentrations: a link between low birth weight and insulin resistance syndrome? Journal of Clinical Endocrinology and Metabolism 83, 757-760.
126. Phillips, D. I. W., Walker, B. R., Reynolds, R. M., Flanagan, D. E. H., Woods, P. J., Osmund, C., Barker, D. J. P. & Whorwood, C. B. (2000). Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 35, 1301-1306.
127. Power, M. L., Bowman, M. E., Smith, R., Zieglar, T. E., Layne, D. G., Schulkin, J. & Tardif, S. D. (2006). Pattern of maternal serum corticotrophin-releasing hormone concentration during pregnancy in the common marmoset (Callithrix jacchus). American Journal of Primatology 68, 181-188.
128. Power, M. L. & Schulkin, J. (2006). Functions of corticotropin-releasing hormone in anthropoid primates: from brain to placenta. American Journal of Human Biology 18, 431-447.
129. Power, M. L., Williams, L. E., Gibson, S. V., Schulkin, J., Helfers, J. & Zorilla, E. P. (2010). Pattern of maternal circulating CRH in laboratory-housed squirrel and owl monkeys. American Journal of Primatology 72, 1004-1012.
130. Rickard, I. J. & Lummaa, V. (2007). The predictive adaptive response and metabolic syndrome: challenges for the hypothesis. Trends in Endocrinology and Metabolism 18, 94-99.
131. Robinson, B. G., Arbiser, J. L., Emanuel, R. L. & Majzoub, J. A. (1989). Species-specific placental corticotropin releasing hormone messenger-RNA and peptide expression. Molecular and Cellular Endocrinology 62, 337-341.
132. Roe, C. M., Leitsch, I. M., Boura, A. L. A. & Smith, R. (1996). Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro. Journal of Clinical Endocrinology and Metabolism 81, 763-769.
133. Romero-Prado, M. M. D., Barrera-Saldana, H. A. & Castrillo-Diez, J. L. (2010). hGH-V gene expression and promoter activity under glucose and 5-azacytidine (5azaC) effects. Gene 452, 7-15.
134. Ryan, E. A. & Enns, L. (1988). Role of gestation hormones in the induction of insulin resistance. The Journal of Clinical Endocrinology and Metabolism 67, 341-347.
135. Sandman, C. A., Glynn, L., Dunkel Schetter, C., Wadhwa, P., Garite, T., Chicz-DeMet, A. & Hobel, C. (2006). Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock. Peptides 27, 1457-1463.
136. Santolaya-Forgas, J., Mehta, S. H. & Castracane, V. D. (2006). A study to determine if acute maternal and fetal hyperglycemia/insulinemia induces leptin production during pregnancy. Hormone and Metabolic Research 38, 598-602.
137. Sapolsky, R. M., Romero, L. M. & Munck, A. U. (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 21, 55-89.
138. Sarker, P., Bergman, K., Fisk, N. M., O'Connor, T. G. & Glover, V. (2007). Ontogeny of foetal exposure to maternal cortisol using midtrimester amniotic fluid as a biomarker. Clinical Endocrinology 66, 636-640.
139. Sarker, P., Bergman, K., O'Connor, T. G. & Glover, V. (2008). Maternal antenatal anxiety and amniotic fluid cortisol and testosterone: possible implications for foetal programming. Journal of Neuroendocrinology 20, 489-496.
140. Schiesel, B., Strasburger, C. J., Bildingmeter, M., Gutt, B., Kirk, S. E., Oberhoffer, R. & Friese, K. (2007). Role of placental growth hormone in the alteratio of maternal arterial resistance to pregnancy. Journal of Reproductive Medicine 52, 313-316.
141. Schneider, S., Freerksen, N., Rohrig, S., Hoeft, B. & Maul, H. (2012). Gestational diabetes and preeclampsia: similar risk factor profiles? Early Human Development 88, 179-184.
142. Schuler, A. M., Brady, A. G., Tustin, G. W., Parks, V. L., Morris, C. G. & Abee, C. R. (2010). Measurement of fetal biparietal diameter in owl monkeys (Aotus nancymaae). Journal of the American Association for Laboratory Animal Science 49, 560-563.
143. Schulkin, J. (1999). Corticotropin-releasing hormone signals adversity in both the placenta and the brain: regulation by glucocorticoids and allostatic overload. Journal of Endocrinology 161, 349-356.
144. Schulte, H. M., Weisner, D. & Allolio, B. (1990). The corticotropin releasing hormone test in late pregnancy: lack of adrenocorticotropin and cortisol response. Clinical Endocrinology 33, 99-106.
145. Seckl, J. R. (2001). Glucocorticoid programming of the fetus: adult phenotypes and molecular mechanisms. Molecular and Cellular Endocrinology 185, 61-71.
146. Seckl, J. R. & Holmes, M. C. (2007). Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nature Clinical Practice 3, 479-488.
147. Setia, S. & Sridha, M. G. (2009). Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming? Hormone and Metabolic Research 41, 791-798.
148. Setia, S., Sridhar, M. G., Bhat, V. & Chaturvedula, L. (2007). Growth hormone in intra-uterine growth retarded newborns. Indian Journal of Pediatrics 74, 991-994.
149. Sheikh, S., Satoshar, P. & Bhartiya, D. (2001). Expression of insulin-like growth factor-I and placental growth hormone in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Molecular Human Reproduction 7, 287-292.
150. Sikafis, S., Akolekar, R., Mantas, N., Kappou, D. & Nicolaides, K. H. (2011). Maternal serum placental growth hormone (hPGH) at 11 to 13 weeks at gestation in preeclampsia. Hypertenstion in Pregnancy 30, 74-82.
151. Sikafis, S., Papadoupoulou, E., Konstantinidou, A., Giahnakis, E., Fragouli, Y., Koumantakis, N. & Kalmanti, M. (2009). Increased levels of placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome. Growth Hormone and IGF Research 19, 121-125.
152. Simopoulos, C., Christodoulou, E., Lambropoulou, M., Tsaroucha, A. K., Kakolyris, S., Polychronidis, A., Karayiannakis, A. J. & Chatzaki, E. (2009). Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Clinical Neuroendocrinology 89, 315-326.
153. Sirianni, R., Mayhew, B. A., Carr, B. R., Parker, C. R. & Rainey, W. E. (2005). Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. Journal of Clinical Endocrinology and Metabolism 90, 5393-5400.
154. Slattery, D. A. & Neumann, I. D. (2008). No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. Journal of Physiology 586, 377-385.
155. Smith, R., Can, E. C., Bowman, M. E., Harewood, W. J. & Phippard, A. F. (1993). Corticotropin-releasing hormone in baboon pregnancy. Journal of Endocrinology and Metabolism 76, 1063-1068.
156. Smith, S. R., de Jonge, L., Pellymounter, M., Nguyen, T., Harris, R., York, D., Redmann, S., Rood, J. & Bray, G. A. (2001). Peripheral administration of human corticotropin releasing hormone: a novel method to increase energy expenditure and fat oxidation in man. Journal of Clinical Endocrinology and Metabolism 86, 1991-1998.
157. Smith, R. & Nicholson, R. C. (2007). Corticotropin releasing hormone and the timing of birth. Frontiers in Bioscience 12, 912-918.
158. Smits, L., Krabbendam, L., de Bie, R., Essed, G. & van Os, J. (2006). Lower birth weight of Dutch neonates who were in utero at the time of the 9/11 attacks. Journal of Psychosomatic Research 61, 715-717.
159. Southcombe, J., Tannetta, D., Redman, C. & Sargent, I. (2011). The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS ONE 6, e20245.
160. Sun, K., Adamson, S. L., Yang, K. & Challis, J. R. G. (1999). Interconversion of cortisol and cortisone by 11 beta-hydroxysteroid hydrogensases type 1 and 2 in the perfused human placenta. Placenta 20, 13-19.
161. Tardif, S., Power, M., Layne, D., Smucny, D. & Zeigler, T. (2004). Energy restriction initiated at different gestational ages has varying effects on maternal weight gain and pregnancy outcome in common marmoset monkeys (Callithrix jacchus). British Journal of Nutrition 92, 841-849.
162. Tardif, S. D., Zeigler, T. E., Power, M. & Layne, D. (2005). Endocrine changes in full-term pregnancies and pregnancy loss due to energy restriction in the common marmoset (Callithrix jacchus). Journal of Clinical Endocrinology and Metabolism 90, 335-339.
163. Teixeira, C., Figueiredo, B., Conde, A., Pacheco, A. & Costa, R. (2009). Anxiety and depression during pregnancy in men and women. Journal of Affective Disorders 119, 142-148.
164. Thomsen, M. (1998). Does the CRH binding protein shield the anterior pituitary from placental CRH. Endocrine 9, 221-226.
165. Thorp, J. A., Jones, P. G., Knox, E. & Clark, R. H. (2002). Does antenatal corticosteroid therapy affect birth weight and head circumference? Obstetrics and Gynecology 99, 101-108.
166. Trivers, R. L. (1974). Maternal-fetal conflict. American Zoologist 14, 249-264.
167. Tsatsanis, C., Dermitzaki, E., Venihaki, M., Chatzaki, E., Minas, V., Gravanis, A. & Margioris, A. N. (2007). The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function. Cellular and Molecular Life Sciences 64, 1638-1655.
168. Tyson, E. K., Smith, R. & Read, M. (2009). Evidence that corticotropin-releasing hormone modulates myometrial contractility during human pregnancy. Endcrinology 150, 5617-5625.
169. Vackova, Z., Vagnerova, K., Libra, A., Miksik, I., Pacha, J. & Staud, F. (2009). Deexamethosone and betamethasone administration during pregnancy affects expression and function of 11 beta-hydroxysteroid dehydrogenase type 2 in the rat placenta. Reproductive Toxicology 28, 46-51.
170. Van Calsteren, K., de Catte, L., Devlieger, R., Chai, D. C. & Amant, F. (2009). Sonographic biometrical normograms and estimation of fetal weight in the baboon (Papio anubis). Journal of Medical Primatology 38, 321-327.
171. Wadhwa, P. D., Garite, T. J., Porto, M., Glynn, L., Chicz-DeMet, A., Dunkel Schetter, C. & Sandman, C. A. (2004). Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. American Journal of Obstetrics and Gynecology 191, 1063-1069.
172. Wadhwa, P. D., Sandman, C. A., Chicz-DeMet, A. & Porto, M. (1997). Placental CRH modulates maternal pituitary-adrenal function in human pregnancy. Annals of the New York Academy of Sciences 814, 276-281.
173. Ward, A. M. V., Syddall, H. E., Wood, P. J., Chrouses, G. P. & Phillips, D. I. W. (2004). Fetal programming of the hypothalamic-pituitary-adrenal (HPA) axis: low birth weight and central HPA regulation. Journal of Clinical Endocrinology and Metabolism 89, 1227-1233.
174. Warren, W. B., Goland, R. S., Wardlaw, S. L., Stark, R. I., Fox, H. E. & Conwell, I. M. (1990). Elevated maternal plasma corticotropin releasing hormone levels in twin gestation. Journal of Perinatal Medicine 18, 39-44.
175. De Weerth, C. & Buitelaar, J. K. (2005). Physiological stress response during human pregnancy: a review. Neuroscience and Biobehavioral Reviews 29, 295-312.
176. Weinstock, M. (2005). The potential influence of maternal stress hormones on development and mental health of the offspring. Brain, Behavior, and Immunity 19, 296-308.
177. Westphal, N. J. & Seasholtz, A. F. (2006). CRH-BP: the regulation and function of a phylogenetically conserved binding protein. Frontiers in Bioscience 11, 1878-1891.
178. Wolfe, C. D. A., Patel, S. P., Linton, E. A., Campbell, E. A., Anderson, J., Dornhorst, A., Lowry, P. J. & Jones, M. T. (1988). Plasma corticotropin-releasing factor (CRF) in abnormal pregnancy. British Journal of Obstetrics and Gynaecology 95, 1003-1006.
179. Woods, R. J., Grossman, A., Saphier, P., Kennedy, K. M., Ur, E., Behan, D., Potter, E., Vale, W. & Lowry, P. J. (1994). Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of he complex. Journal of Clinical Endocrinology and Metabolism 78, 73-76.
180. Young, S. F. & Rose, J. C. (2002). Attenuation of corticotropin-releasing hormone and arginine vasopressin responsiveness during late-gestation pregnancy in sheep. Biology of Reproduction 66, 1805-1812.
181. Zhang, L. M., Wang, Y. K., Hui, N., Sha, J. Y., Chen, X., Guan, R., Dai, L., Gao, L., Yuan, W. J. & Ni, X. (2008). Corticoropin-releasing hormone acts on CRH-R1 to inhibit the spontaneous contractility of non-labouring human myometrium at term. Life Sciences 83, 620-624.
182. Zhu, H., Wang, J. & Li, J. (2011). Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery? Inflammation Research 60, 715-721.